COVID-19: New Administration Code 0074A for Pfizer Pediatric Vaccine Booster Dose

On May 17, 2022, the FDA amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5-11 years old. CMS issued a new code, effective May 17, 2022, for the vaccine administration:

Code: 0074A

Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation.

Short descriptor: ADM SARSCV2 10MCG TRS-SUCR B

Source: https://med.noridianmedicare.com/web/jfb/article-detail/-/view/10534/covid-19-new-administration-code-0074a-for-pfizer-pediatric-vaccine-booster-dose